[go: up one dir, main page]

BR9911250A - Processo para preparação de compostos - Google Patents

Processo para preparação de compostos

Info

Publication number
BR9911250A
BR9911250A BR9911250-7A BR9911250A BR9911250A BR 9911250 A BR9911250 A BR 9911250A BR 9911250 A BR9911250 A BR 9911250A BR 9911250 A BR9911250 A BR 9911250A
Authority
BR
Brazil
Prior art keywords
preparing compounds
useful
formula
preparation
therapeutic agents
Prior art date
Application number
BR9911250-7A
Other languages
English (en)
Inventor
Ian Frank Cottrell
Ulf H Dolling
David Hands
Robert Darrin Wilson
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of BR9911250A publication Critical patent/BR9911250A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"PROCESSO PARA PREPARAçãO DE COMPOSTOS" A presente invenção diz respeito a um processo para a preparação de derivados de morfolina da fórmula (I) que são úteis como agentes terapêuticos.
BR9911250-7A 1998-06-16 1999-06-10 Processo para preparação de compostos BR9911250A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9813025.5A GB9813025D0 (en) 1998-06-16 1998-06-16 Chemical synthesis
PCT/GB1999/001842 WO1999065900A1 (en) 1998-06-16 1999-06-10 Chemical synthesis of morpholine derivatives

Publications (1)

Publication Number Publication Date
BR9911250A true BR9911250A (pt) 2001-03-13

Family

ID=10833892

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9911250-7A BR9911250A (pt) 1998-06-16 1999-06-10 Processo para preparação de compostos

Country Status (28)

Country Link
US (2) US6297376B1 (pt)
EP (1) EP1087966B1 (pt)
JP (2) JP4647783B2 (pt)
KR (1) KR100619589B1 (pt)
CN (1) CN1131864C (pt)
AR (1) AR018877A1 (pt)
AT (1) ATE217308T1 (pt)
AU (1) AU746721B2 (pt)
BR (1) BR9911250A (pt)
CA (1) CA2334821C (pt)
CZ (1) CZ299257B6 (pt)
DE (1) DE69901444T2 (pt)
DK (1) DK1087966T3 (pt)
EA (1) EA003468B1 (pt)
ES (1) ES2176036T3 (pt)
GB (1) GB9813025D0 (pt)
HR (1) HRP20000878B1 (pt)
HU (1) HUP0102867A3 (pt)
IL (2) IL139946A0 (pt)
NZ (1) NZ508558A (pt)
PL (1) PL196778B1 (pt)
PT (1) PT1087966E (pt)
SI (1) SI1087966T1 (pt)
SK (1) SK283380B6 (pt)
TW (1) TW526199B (pt)
UA (1) UA66866C2 (pt)
WO (1) WO1999065900A1 (pt)
YU (1) YU76500A (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR030284A1 (es) 2000-06-08 2003-08-20 Merck & Co Inc Proceso para la sintesis de (2r, 2-alfa-r,3a) -2-[1-(3,5-bis(trifluorometil) fenil) etoxi]-3-(4-fluorofenil)-1,4-oxazina; dicho compuesto y sus formas polimorficas
GB0014876D0 (en) * 2000-06-16 2000-08-09 Merck Sharp & Dohme Chemical synthesis
UA76810C2 (uk) 2001-12-10 2006-09-15 Мерк Енд Ко., Інк. Фармацевтична композиція антагоніста рецептора тахікініну у формі наночастинок
AR039625A1 (es) 2002-04-18 2005-03-02 Merck & Co Inc Proceso para la preparacion de 5-((2(r)--(1(r)- (3,5-bis (trifluormetil) fenil)etoxi-3 (s) - (4-fluorfenil) -4-morfolinil) metil) -1,2-dihidro-3h-1,2,4-triazol-3-ona
US7235671B2 (en) 2002-08-21 2007-06-26 Merck & Co. Inc. Process for preparing 3-chloromethyl-1,2,4-triazolin-5-one
KR20080089659A (ko) * 2006-02-03 2008-10-07 그렌마크 파머수티칼스 엘티디. 아프레피탄트의 비정질 및 결정 형태 및 그것의 제조 방법
WO2012146692A1 (en) 2011-04-29 2012-11-01 Sandoz Ag Novel intermediates for the preparation of highly pure aprepitant or fosaprepitant
ITMI20130273A1 (it) * 2013-02-26 2014-08-27 Olon Spa Procedimento per la preparazione di aprepitant
CN103288813A (zh) * 2013-06-04 2013-09-11 四川百利药业有限责任公司 一种阿瑞匹坦的制备方法
CN104628663A (zh) * 2013-11-08 2015-05-20 中山奕安泰医药科技有限公司 3-氯甲基-1,2,4-三唑啉-5-酮的合成方法
CN107698574B (zh) * 2017-11-23 2020-12-01 中山奕安泰医药科技有限公司 一种高纯度阿瑞匹坦的精制制备工艺
CN109485613B (zh) * 2018-11-21 2022-05-13 江苏慧聚药业股份有限公司 阿瑞匹坦和福沙匹坦边链片段的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111960A (en) * 1993-12-17 1999-12-22 Merck & Co Inc Morpholines and thiomorpholines their preparation and pharmaceutical compositions containing them
JP3071467B2 (ja) * 1993-12-29 2000-07-31 メルク シヤープ エンド ドーム リミテツド 置換モルホリン誘導体およびその治療剤としての使用
IL112778A0 (en) 1994-03-04 1995-05-26 Merck & Co Inc Substituted heterocycles, their preparation and pharmaceutical compositions containing them
AU690682B2 (en) 1994-05-05 1998-04-30 Merck Sharp & Dohme Limited Morpholine derivatives and their use as antagonists of tachikinins

Also Published As

Publication number Publication date
US6297376B1 (en) 2001-10-02
DK1087966T3 (da) 2002-07-08
CA2334821A1 (en) 1999-12-23
HRP20000878A2 (en) 2001-12-31
PT1087966E (pt) 2002-10-31
HUP0102867A2 (hu) 2002-05-29
DE69901444D1 (de) 2002-06-13
HUP0102867A3 (en) 2004-06-28
SI1087966T1 (en) 2002-10-31
JP2002518388A (ja) 2002-06-25
EP1087966A1 (en) 2001-04-04
AU746721B2 (en) 2002-05-02
SK283380B6 (sk) 2003-06-03
CZ20004734A3 (cs) 2001-08-15
JP2010195808A (ja) 2010-09-09
CN1305475A (zh) 2001-07-25
US20020019524A1 (en) 2002-02-14
WO1999065900A1 (en) 1999-12-23
YU76500A (sh) 2003-02-28
PL196778B1 (pl) 2008-01-31
TW526199B (en) 2003-04-01
ES2176036T3 (es) 2002-11-16
GB9813025D0 (en) 1998-08-12
EA200100040A1 (ru) 2001-06-25
SK19212000A3 (sk) 2001-07-10
IL139946A (en) 2007-05-15
CA2334821C (en) 2009-02-03
US6407255B2 (en) 2002-06-18
HRP20000878B1 (en) 2009-09-30
ATE217308T1 (de) 2002-05-15
IL139946A0 (en) 2002-02-10
UA66866C2 (uk) 2004-06-15
KR20010052886A (ko) 2001-06-25
AU4281399A (en) 2000-01-05
JP4647783B2 (ja) 2011-03-09
CN1131864C (zh) 2003-12-24
JP5285652B2 (ja) 2013-09-11
EP1087966B1 (en) 2002-05-08
EA003468B1 (ru) 2003-06-26
AR018877A1 (es) 2001-12-12
CZ299257B6 (cs) 2008-05-28
NZ508558A (en) 2003-07-25
DE69901444T2 (de) 2002-11-28
KR100619589B1 (ko) 2006-09-05
PL344581A1 (en) 2001-11-05

Similar Documents

Publication Publication Date Title
BR0210464A (pt) Composto, composição farmacêutica, processo para preparar um composto, e, uso de um composto
BR0010555A (pt) Inibidores de neuraminidases
BR0206433A (pt) Composto, composição farmacêutica, processo para a prepapação de um composto, e, uso de um composto
BR0312729A (pt) Novos derivados de indol-3-enxofre
BR9916282A (pt) Composto, uso de um um composto e método de tratamento
BR9911482A (pt) Composto, composição farmacêutica, uso do composto, e, processos para o tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto
BR9909844A (pt) Processo para sintetizar um composto, e, composto.
BR0209127A (pt) compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos
BR0112093A (pt) Derivados de sulfonil-pirrolidina úteis no tratamento de distúrbios neurológicos
BR0114252A (pt) Derivados de nitrosodifenilamina
BR0013311A (pt) Derivados substituìdos de 1,5-dihidropirrol-2-ona eficazes como antagonistas de receptores nmda para o tratamento de estados de dor
BR9911250A (pt) Processo para preparação de compostos
BR0014808A (pt) Processos de preparação de um composto, e, compostos nitroaromáticos
BR0301667A (pt) Processo para a preparação de polìmeros em emulsão com pureza elevada
BR9807988A (pt) Processo para a preparação de um composto, e, composto.
BR9916807A (pt) Antagonistas de 5ht1 para terapia antidepressiva
BR9808854A (pt) Processo para preparação de um composto, e, composto
BRPI0108990B8 (pt) processo para preparação de derivados de pirimidona com atividade antifungos
BR9911559A (pt) Processo para a preparação de um composto, composto, processo para o tratamento de tumores resistentes a medicamento múltiplo, uso de um composto, e, agente e composição para tratar tumores resistentes a medicamento múltiplo.
BRPI0411308A (pt) composto, composição farmacêutica, processo para a preparação de um composto, e, uso de um composto
BR0113259A (pt) Processo para a preparação de um composto, composto e processo para a preparação de compostos
BR0016638B1 (pt) compostos anÁlogos de homopiperidilbenzimidazàis substituÍdos como relaxantes féndicos, processo para preparar os mesmos, composiÇço farmacÊutica e processo para preparÁ-la.
PT1206452E (pt) Processo de preparacao de compostos benzoper-hidroisoindole
BR0113170A (pt) Processo para a preparação de dinapsolina
PA8450901A1 (es) Derivados de eritromicina

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O E 13 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]